Abiopharma

🔍 Putnam Adam (Director)

Company: ALICO, INC. (ALCO)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 789 shares of Alico, Inc., Common Stock, Par Value $1.00 at $41.21 per share (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 17,699.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: These shares were issued under the Amended and Restated Stock Incentive Plan of 2015.